Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies

Published:2021-03-01 Issue:2 Volume:36 Page:362-370
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Mi-Kyeong,Park Hae-Sim,Park Choon-Sik,Min Soung-Jun,Albers Frank C.,Yancey Steven W.,Mayer Bhabita,Kwon Namhee

Funder

GlaxoSmithKline

Korea Health Industry Development Institute

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2019-198.pdf

Reference20 articles.

1. Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

3. Severe asthma: future treatments

4. Development of New Therapies for Severe Asthma

5. Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial;ERJ Open Research;2024-02-08

2. Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review;Cureus;2023-12-01

3. Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study;European Respiratory Journal;2022-07-26

4. Anti-IL-5 therapies for asthma;Cochrane Database of Systematic Reviews;2022-07-12

5. Biological Therapy in Refractory Chronic Rhinosinusitis with Nasal Polyp;Journal of Clinical Otolaryngology Head and Neck Surgery;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3